The Claim
Magnesium deficiency impairs insulin signaling by reducing insulin receptor tyrosine kinase activity.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Low magnesium levels decrease the activity of insulin receptor tyrosine kinase, which reduces the effectiveness of insulin signaling.
See the scientific wording
Magnesium deficiency impairs insulin signaling by reducing insulin receptor tyrosine kinase activity.
When magnesium is low, the insulin receptor cannot activate properly because magnesium is needed for its enzyme to work. This stops the receptor from sending signals inside the cell, so glucose cannot enter muscle and fat cells, causing blood sugar to rise.
What the research says
1 studyStudy: Magnesium Deficiency and Its Impact on the Development of Insulin Resistance in Obese Individuals
When people don't get enough magnesium, their body has a harder time using insulin to control blood sugar — this study found that obese people with low magnesium had much worse insulin function, which matches the idea that magnesium helps insulin work properly.
Related videos
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.